Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128988) titled 'Ciprofol Accelerates Early Postoperative Immune Reconstitution in Lung Cancer Patients by Maintaining Mitochondrial Metabolic Flexibility: A Randomized Controlled Trial' on July 29.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)
Condition:
Non-small cell lung cancer
Intervention:
Ciprofol Group:Induction: 0.4 - 0.5 mg/kg, administered slowly
Maintenance: Initial infusion rate 1.0 mg/kg/h. Adjust according to BIS value (target 40 - 60) in real time, and make adjustments every 5 minutes.
Propofol G...